EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The impact of different anticoagulants and antiplatelets regimens on acute epistaxis outcomes

Elchanan Zloczower, Sapir Pinhas, Raviv Allon, Adi Syn-Hershko, Tom Raz Yarkoni, Maayan Marom, David Kiderman, Oded Cohen, Meir Warman

European Archives of Oto-Rhino-Laryngology · 2024-09 · 281 (9) · 4863-4871

DOI: 10.1007/s00405-024-08718-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, online erschienen am 23.05.2024. Verfasst von Elchanan Zloczower und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, Kaplan Medical Center, Rehovot, Israel. chanani9@gmail.com. Hauptthemen laut MEDLINE: Epistaxis, Anticoagulants, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hebrew University of Jerusalem.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The impact of anticoagulants (AC) and antiplatelets (AP) on the management of acute epistaxis remains unclear. This study investigated the association between AC/AP therapy and treatment outcomes in patients with acute epistaxis. Methodology A retrospective analysis of patients presented to the otolaryngology emergency room with acute epistaxis (2014–2022). Patients were categorized based on their regular medications: AP, dual AP therapy (DAPT), new oral anticoagulants (NOAC), vitamin K antagonists (VKA), or no regular AC/AP use (control group). Outcome measures included rates of minor interventions (chemical or electrical cautery, nasal tamponade), major interventions (endoscopic ligation, embolization), recurrent emergency department visits, admission rates, and duration.

Results

786 patients were included with an average follow-up period of 52.56 ± 20.4 months. Compared to the control group, patients on AP, DAPT, or VKA had significantly higher rates of minor interventions (63.1% vs. 74.4%, 79.6%, and 77.3%, respectively, p < 0.05). DAPT users exhibited a higher rate of major interventions than the control (5.6% vs. 1.3%, p = 0.053). NOAC users showed no significant difference in minor interventions compared to control and required no major interventions. Both NOAC and VKA users had significantly higher rates of recurrent epistaxis events and prolonged hospitalization compared to the control (p < 0.01 and p < 0.05, respectively).

Conclusions

NOAC demonstrated more favorable outcomes than VKA in patients with acute epistaxis, and DAPT use was associated with an increased need for major interventions. These findings suggest a more conservative approach in NOAC users than other AC/AP agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpistaxisAnticoagulantsPlatelet Aggregation InhibitorsHumansFemaleMaleRetrospective StudiesMiddle AgedAgedAcute DiseaseTreatment OutcomeAdultEmergency Service, HospitalEndoscopy

Stichwörter der Autor:innen

Acute epistaxisAnticoagulationAntiplateletNew oral anticoagulation

Substanzen

AnticoagulantsPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Department of Otolaryngology, Head and Neck Surgery, Kaplan Medical Center, Rehovot, Israel. chanani9@gmail.com.
  • Department of Otolaryngology, Head and Neck Surgery, Kaplan Medical Center, Rehovot, Israel.
  • Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Joyce and Irvin Goldman Medical School, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheba, Israel.
  • Division of Otorhinolaryngology, Faculty of Health Sciences, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheba, Israel.

Förderung

  • Hebrew University of Jerusalem

Zitieren

APA

Zloczower, E., Pinhas, S., Allon, R., Syn-Hershko, A., Raz Yarkoni, T., Marom, M., Kiderman, D., Cohen, O., & Warman, M. (2024). The impact of different anticoagulants and antiplatelets regimens on acute epistaxis outcomes. European Archives of Oto-Rhino-Laryngology, 281(9), 4863-4871. https://doi.org/10.1007/s00405-024-08718-6

Vancouver

Zloczower E, Pinhas S, Allon R, Syn-Hershko A, Raz Yarkoni T, Marom M, et al. The impact of different anticoagulants and antiplatelets regimens on acute epistaxis outcomes. European Archives of Oto-Rhino-Laryngology. 2024;281(9):4863-4871. doi:10.1007/s00405-024-08718-6

BibTeX
@article{Zloczower2024,
  author = {Zloczower, Elchanan and Pinhas, Sapir and Allon, Raviv and Syn-Hershko, Adi and Raz Yarkoni, Tom and Marom, Maayan and Kiderman, David and Cohen, Oded and Warman, Meir},
  title = {The impact of different anticoagulants and antiplatelets regimens on acute epistaxis outcomes},
  journal = {European Archives of Oto-Rhino-Laryngology},
  year = {2024},
  volume = {281},
  number = {9},
  pages = {4863--4871},
  doi = {10.1007/s00405-024-08718-6}
}
Kostenlos starten →